This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Feb 16;325(7):644-645.

doi: 10.1001/jama.2021.0585.

Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19

Preeti N Malani^{1

2}, Robert M Golub³

Affiliations

Affiliations

¹ Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor.
² Associate Editor, JAMA.
³ Deputy Editor, JAMA.

PMID: 33475716
DOI: 10.1001/jama.2021.0585

Editorial

Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19

Preeti N Malani et al. JAMA. 2021.

. 2021 Feb 16;325(7):644-645.

doi: 10.1001/jama.2021.0585.

Authors

Preeti N Malani^{1

2}, Robert M Golub³

Affiliations

¹ Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor.
² Associate Editor, JAMA.
³ Deputy Editor, JAMA.

PMID: 33475716
DOI: 10.1001/jama.2021.0585

No abstract available

PubMed Disclaimer

Comment on

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Gottlieb RL, Nirula A, Chen P, Boscia J, Heller B, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, Shawa I, Kumar P, Adams AC, Van Naarden J, Custer KL, Durante M, Oakley G, Schade AE, Holzer TR, Ebert PJ, Higgs RE, Kallewaard NL, Sabo J, Patel DR, Klekotka P, Shen L, Skovronsky DM. Gottlieb RL, et al. JAMA. 2021 Feb 16;325(7):632-644. doi: 10.1001/jama.2021.0202. JAMA. 2021. PMID: 33475701 Free PMC article. Clinical Trial.

Similar articles

Neutralizing SARS-CoV-2.
Poeschla E. Poeschla E. Elife. 2020 Dec 15;9:e64496. doi: 10.7554/eLife.64496. Elife. 2020. PMID: 33320086 Free PMC article.
Monoclonal Antibody for Patients with Covid-19.
Jaworski JP. Jaworski JP. N Engl J Med. 2021 Mar 25;384(12):1170-1171. doi: 10.1056/NEJMc2100221. Epub 2021 Feb 3. N Engl J Med. 2021. PMID: 33534967 No abstract available.
Monoclonal Antibody for Patients with Covid-19. Reply.
Lundgren JD, Lane HC, Neaton JD. Lundgren JD, et al. N Engl J Med. 2021 Mar 25;384(12):1171. doi: 10.1056/NEJMc2100221. Epub 2021 Feb 3. N Engl J Med. 2021. PMID: 33534968 No abstract available.
Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.
Wan J, Xing S, Ding L, Wang Y, Gu C, Wu Y, Rong B, Li C, Wang S, Chen K, He C, Zhu D, Yuan S, Qiu C, Zhao C, Nie L, Gao Z, Jiao J, Zhang X, Wang X, Ying T, Wang H, Xie Y, Lu Y, Xu J, Lan F. Wan J, et al. Cell Rep. 2020 Jul 21;32(3):107918. doi: 10.1016/j.celrep.2020.107918. Epub 2020 Jul 3. Cell Rep. 2020. PMID: 32668215 Free PMC article.
Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.
Wang X, Huang K, Jiang H, Hua L, Yu W, Ding D, Wang K, Li X, Zou Z, Jin M, Xu S. Wang X, et al. Virol Sin. 2020 Dec;35(6):793-802. doi: 10.1007/s12250-020-00308-0. Epub 2020 Nov 6. Virol Sin. 2020. PMID: 33156486 Free PMC article.

See all similar articles

Cited by

The Treatment of COVID-19 With Monoclonal Antibody Therapy: Patient-Reported Outcomes.
Lamour D, Vafadari N, Clayton LM, Solano JJ, Hughes PG, Shih RD, Alter SM. Lamour D, et al. Cureus. 2022 Sep 16;14(9):e29247. doi: 10.7759/cureus.29247. eCollection 2022 Sep. Cureus. 2022. PMID: 36277574 Free PMC article.
A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2.
Miranda MNS, Pingarilho M, Pimentel V, Torneri A, Seabra SG, Libin PJK, Abecasis AB. Miranda MNS, et al. Front Microbiol. 2022 Jun 2;13:889643. doi: 10.3389/fmicb.2022.889643. eCollection 2022. Front Microbiol. 2022. PMID: 35722303 Free PMC article. Review.
Outpatient Management of COVID-19 With Monoclonal Antibody Therapy in a Young Renal Transplant Patient.
Malik B, Kalantary A, Rikabi K, Abdelazeem B, Kunadi A. Malik B, et al. Cureus. 2021 Sep 3;13(9):e17672. doi: 10.7759/cureus.17672. eCollection 2021 Sep. Cureus. 2021. PMID: 34650851 Free PMC article.
Contemporary narrative review of treatment options for COVID-19.
Shang L, Lye DC, Cao B. Shang L, et al. Respirology. 2021 Aug;26(8):745-767. doi: 10.1111/resp.14106. Epub 2021 Jul 8. Respirology. 2021. PMID: 34240518 Free PMC article. Review.
COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view.
Vitiello A, Porta R, Pianesi L, Ferrara F. Vitiello A, et al. Ir J Med Sci. 2022 Feb;191(1):487-488. doi: 10.1007/s11845-021-02584-5. Epub 2021 Mar 12. Ir J Med Sci. 2022. PMID: 33710481 Free PMC article. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information